UPC Analytics
ENDE
Overview · Filed:

ORD_3577/2025

NOVEL ANTITUMORAL USE OF CABAZITAXEL

Procedural & sub-applicationsCase Management OrdersMunich LDGeneric Order
  • 2025-01-22Procedural onlyproceduralGeneric Order

    The Munich Local Division issued a case-management order following a preliminary interim conference in Sanofi's infringement actions (four separate cases) against multiple generic-drug defendants (Accord, STADA, Dr. Reddy's, Zentiva), setting the value of infringement claims and counterclaims, directing Sanofi to remedy formal deficiencies in its pleadings, and waiving all other outstanding deadlines pending clarification.